Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Mehr anzeigen
Spyre Therapeutics to Participate in Upcoming Investor Conference PR Newswire WALTHAM, Mass., Sept. 10, 2024 WALTHAM, Mass., Sept. 10, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ:...
Spyre Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Aug. 7, 2024 Initiated dosing in Phase 1 trial of SPY001, an anti-α4β7...
NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease PR...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.77 | -5.85317460317 | 30.24 | 31.89 | 27.64 | 1190454 | 29.39589749 | CS |
| 4 | 0.04 | 0.140696447415 | 28.43 | 31.89 | 26.52 | 648846 | 29.03322095 | CS |
| 12 | 2.76 | 10.7351225204 | 25.71 | 32.41 | 23.31 | 520049 | 28.26505063 | CS |
| 26 | -8.88 | -23.7751004016 | 37.35 | 40.835 | 22.19 | 499206 | 29.80331358 | CS |
| 52 | 17.66 | 163.367252544 | 10.81 | 47.97 | 10.42 | 456599 | 29.71143998 | CS |
| 156 | 17.66 | 163.367252544 | 10.81 | 47.97 | 10.42 | 456599 | 29.71143998 | CS |
| 260 | 17.66 | 163.367252544 | 10.81 | 47.97 | 10.42 | 456599 | 29.71143998 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
